Cargando…
A Review of Nebivolol Pharmacology and Clinical Evidence
Nebivolol is a highly selective β(1)-adrenergic receptor antagonist with a pharmacologic profile that differs from those of other drugs in its class. In addition to cardioselectivity mediated via β(1) receptor blockade, nebivolol induces nitric oxide-mediated vasodilation by stimulating endothelial...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541699/ https://www.ncbi.nlm.nih.gov/pubmed/26177892 http://dx.doi.org/10.1007/s40265-015-0435-5 |